Patents by Inventor Christophe Panichelli

Christophe Panichelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7041502
    Abstract: A peptide, previously identified as a binding partner of HLA-B44, has now been found to bind to HLA-B18 forming a T cell epitope. The therapeutic and diagnostic ramifications of this are the subject of this invention, as are various products obtained in the course of the development of the invention.
    Type: Grant
    Filed: June 5, 2002
    Date of Patent: May 9, 2006
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Janine Bilsborough, Erwin Schultz, Christophe Panichelli, Thierry Boon, Pierre Van der Bruggen
  • Publication number: 20030228325
    Abstract: A peptide, previously identified as a binding partner of HLA-B44, has now been found to bind to HLA-B18 forming a T cell epitope. The therapeutic and diagnostic ramifications of this are the subject of this invention, as are various products obtained in the course of the development of the invention.
    Type: Application
    Filed: June 5, 2002
    Publication date: December 11, 2003
    Inventors: Janine Bilsborough, Erwin Schultz, Christophe Panichelli, Thierry Boon-Falleur, Pierre Van der Bruggen